Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Epigenetic Regulation01:37

Epigenetic Regulation

3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K
Histone Modification02:32

Histone Modification

3.4K
3.4K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

6.3K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Targeted Epigenetic Activation of <i>CTLA4</i> in Haploinsufficiency Cellular Models by CRISPRa.

Biomedicines·2026
Same author

Sleep Maintenance Insomnia in Older Adults: Cardiometabolic Comorbidities and Evidence of Antiviral Pathways Activation from Blood Transcriptome and dsRNA Expression Analyses.

International journal of molecular sciences·2026
Same author

CD4+ T cells in Type 1 Diabetes: Inferring Stage-specific Dysregulation from scRNA-seq.

Genomics, proteomics & bioinformatics·2026
Same author

Analysis of HERV-K (HML2) Expression in Colorectal Cancer Samples.

Epigenomes·2026
Same author

Single-Cell RNA-Seq Profiling of Transposable Element Expression in Human Peripheral Blood Cells During Viral Infections.

International journal of molecular sciences·2026
Same author

Inference of SARS-CoV-2 exposure biomarkers using large-scale T-cell repertoire profiling.

Genome medicine·2026

相关实验视频

Updated: Jul 12, 2025

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

6.5K

目前的表观遗传疗法方法.

Ekaterina D Griazeva1, Daria M Fedoseeva1, Elizaveta I Radion1

  • 1Federal State Budgetary Institution, Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency, Pogodinskaya Str., 10, Building 1, Moscow 119121, Russia.

Epigenomes
|October 24, 2023
PubMed
概括

表观遗传疗法使用小分子和创新的dCas9或小非编码RNA方法提供了新的疾病治疗方法. 本综述涵盖了目前的研究,应用和表观遗传疗法的局限性.

关键词:
它们是DNA DNA DNA DNA.临床试验是指临床试验中的临床试验.表观遗传学是指表观遗传学.基因治疗的基因疗法基因组 基因组 基因组创新药物 创新药物 创新药物模块化调制的方法药理学 药理学 药理学 药理学 药理学

更多相关视频

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.5K
Methylated DNA Immunoprecipitation
21:24

Methylated DNA Immunoprecipitation

Published on: January 2, 2009

23.4K

相关实验视频

Last Updated: Jul 12, 2025

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

6.5K
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.5K
Methylated DNA Immunoprecipitation
21:24

Methylated DNA Immunoprecipitation

Published on: January 2, 2009

23.4K

科学领域:

  • 生物医学科学 生物医学科学
  • 分子生物学分子生物学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 表观遗传疗法是一个快速发展的领域,具有治疗各种疾病的巨大潜力.
  • 目前的治疗策略主要涉及小分子,其中一些已经在临床使用中.
  • 新兴的方法利用了像dCas9和非编码RNAs这样的新技术.

研究的目的:

  • 提供关于表观遗传疗法当前研究环境的全面概述.
  • 讨论表观遗传疗法中既定和新兴的方法.
  • 评估表观遗传治疗应用的未来前景和固有的局限性.

主要方法:

  • 关于表观遗传疗法的当前科学文献的综述.
  • 分析使用小分子建立的药理学方法.
  • 探索创新技术,包括基于dCas9的基因编辑和小型非编码RNA.

主要成果:

  • 小分子表观遗传药物代表了临床上最先进的治疗策略.
  • 基于dCas9的系统和小型非编码RNA正在积极研究治疗潜力.
  • 该领域的特点是具有不同发展阶段的多样化的方法.

结论:

  • 表观遗传疗法在治疗广泛疾病方面具有相当大的前景.
  • 进一步的研究对于克服局限性和充分实现各种表观遗传策略的潜力至关重要.
  • 药理学和新型分子方法的整合可能决定了表观遗传医学的未来.